Ostomy Care Market Size, Share & Trends Analysis Report By Product (Stoma/Ostomy Bags, Ostomy Accessories), By System (One-piece System, Two-piece Systems), By Usage (Drainable Ostomy Care Products, Closed-end Ostomy Care Products), By Shape (Flat Ostomy Care Products, Convex Ostomy Care Products), By End-User (Hospitals, Post-Acute Care Center, Home Care) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Ostomy Care Market Size

The global ostomy care market size was valued at USD 3.49 billion in 2024 And is projected to reach from USD 3.62 billion in 2025 to USD 5.07 billion by 2033, growing at a CAGR of 3.80% during the forecast period (2025–2033).

The significant incidence of disorders, particularly Inflammatory Bowel Disease (IBD) and colorectal malignancies constitutes a pivotal determinant in the expansion of the market.

A stoma, also known as a bowel diversion, is an ostomy opening in the abdomen to remove bowel and bladder waste. The objective is to enable feces or urine to bypass the diseased or damaged portion of the intestine or bladder. Stomas may be temporary or permanent and require specialized treatment for effective management.

The ostomy care product is administered to patients following ostomy surgery. Primarily, they are required to treat chronic diseases such as colon, prostate, and bladder cancer, Crohn's disease, and ulcerative colitis. Ostomy bags, seals, barrier rings, pouch covers, pouch closures, and stoma caps are commonly used stoma/ostomy care devices. These airtight and watertight devices are affixed to the abdominal wall to collect waste and can be discarded as needed.

Global Ostomy Care Market Growth Factors

Prevalence of Diseases Resulting in Ostomy Surgery

The global load of inflammatory bowel disease (IBD) is increasing, with significant variation in the disease's trends and levels in different economies and regions. In 2017, there had been 6.8 million instances of IBD globally. In 2015, an expected 1.3% of US adults (3 million) were diagnosed with IBD (either Crohn's disease or ulcerative colitis). With increased industrialization, countries in developing economies will have to deal with high incidences of IBD.

Colorectal cancer is the third most common cancer among men worldwide and the second most common cancer among women. In 2019, 1.9 million new colorectal cancers were reported. According to the Globocan Report 2020, the incidence rate is in highly prosperous Asia-Pacific countries and North America. Thus, the high prevalence of diseases, especially IBD and colorectal cancers, is a major factor in the ostomy care market growth.

Advanced Technology in Ostomy Care Products

In recent years, there has been an immense need for innovative ostomy products that meet the requirements of stoma patients. Currently, the market is transforming due to product innovations and the development of advanced personalized ostomy care products that ensure effective management of ostomy non-invasively and in an aesthetically appealing manner.

Innovative personalized/customized ostomy products with advanced features will enhance ostomates' overall quality of life by enhancing physical freedom and functional status. Hence, market players are increasing R&D investments to address challenges associated with ostomy care products. For instance, ConvaTec's R&D expenditure accounted for 4.3% of the total revenue in FY 2020 compared to 2.9% in FY 2019. Thus, increased innovation and capabilities in new ostomy care products drive the market.

Restraining Factors

Complications Related to Ostomy Care Products

Individuals afflicted with stomas encounter a multitude of difficulties. Occasionally, these issues may manifest severely, necessitating medical attention, product modification, evaluation of dietary habits, and adoption of a different lifestyle. Some complications can be self-managed, while others require nursing and specialists' interventions to resolve the issues. The complications faced by patients undergoing stoma surgery include leaks, skin issues/irritation, sore skin and diarrhea, loose tools and ballooning, hernias, and prolapses. Thus, such complications associated with ostomy care products are expected to restrict market growth.

Market Opportunities

Emergence of Next-Generation Ostomy Care

Several new start-ups are coming out with innovative ostomy care devices to resolve ostomates' complications. For instance, TIES Solution is an innovative medical solution for patients with a new or existing permanent ileostomy. It has the potential to improve the quality of life of ileostomy patients. The solution consists of a titanium implant attached to the colon, creating a stable ileostomy, and a cap or hatch cap that "clicks" onto the implant so the patient can use the stoma easily emptied with a conventional ostomy bag. The patient is practically bag-free.

Furthermore, the Alfred smart bag is the world's first smart ostomy bag with wireless connectivity for data collection and synchronization to the Cloud via Bluetooth and mobile data. A potential benefit is that the device can prevent unplanned bag-filling, bag breakage, and sudden breakdowns at night/work. The device improves the quality of life for patients who frequently worry about leaks. Hence, increased innovations will likely create opportunities for the ostomy care market growth.

Regional Insights

Europe: Dominant region with 2.96% market share

Europe is the most significant global market shareholder and is anticipated to exhibit a CAGR of 2.96% during the forecast period. Europe is growing at a promising rate and expects to grow during the forecast period. Germany, the UK, France, Italy, and Spain are the major revenue generators in the region. The region's aging population is a major growth factor for the increasing application of ostomy care products. The growing geriatric population is at a greater risk of developing chronic illnesses like inflammatory bowel disease, colorectal cancer, and bladder cancer. People aged 85 years and older expect to increase from 14 million to 19 million by 2021, and it will reach 40 million by 2050.

Furthermore, the region's major contributing aspect to the market is the increasing prevalence rate of IBD and colorectal cancers. The prevalence of Crohn's disease ranges from 1.5 to 213 cases per 100,000, and ulcerative colitis ranges from 2.4 to 294 per 100,000. Currently, 0.3% of the European population suffers from IBD, which accounts for around 2.5–3 million people.

North America: Fastest growing region with the highest CAGR

North America is estimated to exhibit a CAGR of 4.07% over the forecast period. Factors contributing to the increasing number of ostomy surgeries include the growing geriatric population, the increasing popularity of minimally invasive surgeries, and advanced surgical procedures. For instance, in the US alone, outpatient surgical practices created a huge demand for surgical procedures. Likewise, market players focus on developing innovative and advanced products that offer improved treatment outcomes using ostomy bags. Therefore, increased innovation and effectiveness of ostomy products to reduce post-surgical complications and risks are influencing the ostomy care market in North America.

In addition, the growing focus of vendors in R&D to develop innovative ostomy care products is likely to impact the market growth significantly. The region has a presence of several vendors, such as Hollister, Cymed, Marlen, 11 Health, and Nu-Hope, offering a diverse range of ostomy care products. Both major and emerging players involved in R&D activities expect to lead to the development of several innovative products over the next few years, thereby positively influencing the market in the region.

The Asia-Pacific ostomy care market is growing at a significant rate and expects to grow at a faster pace during the forecast period. Some factors contributing to the region's growth are the presence of a large patient population with acute and chronic diseases, improvements in healthcare infrastructure, and increased healthcare expenditure. The UNFPA reported that the elderly people population is rising at an unprecedented rate, and this region is at the forefront of the global phenomenon of population aging. In the Asia-Pacific region, one in four people will be over 60 years old by 2050. By 2050, the senior population in the region will triple, reaching 1.3 billion. In addition, the surging prevalence of diseases, such as inflammatory bowel diseases, colorectal cancers, bladder cancer, accident-related injuries, and an aging population, are significant factors propelling the regional market.

In Latin America, the region's increased prevalence of several acute and chronic conditions is associated with the aging population, which will likely offer growth opportunities. According to a study by Science Direct, the incidences of CD and UC increased by 140.6% and 333.3%. The prevalence of CD is 41.4, and UC is 44.3 in Latin America. One of the five leading cancers in Latin America is colorectal cancer. The Globocan 2020 estimated that the incidence of CRC was 134,943, with a mortality of 69,435 in Latin America. Such a high risk due to increased disease burden and the aging population drives the higher demand for ostomy surgeries. Therefore, the growing demand for ostomy surgeries is likely to expand the growth of the ostomy care market in Latin America.

Ostomy Care Market Segmentation Analysis

By Products

The market is segmented into ostomy bags and accessories. The ostomy bags segment owns the highest ostomy care market share and is estimated to exhibit a CAGR of 3.89% during the forecast period. The ostomy bag segment is growing faster than the ostomy accessories segment owing to their daily usage among ostomates. This recurring usage pattern leads to a high consumption of ostomy bags during ostomy management. Both global and local/regional players offer a diverse range of ostomy bags catering to the end-user's requirements. Since ostomates require ostomy bags regularly, most manufacturers are concentrating on offering a comprehensive range of bags according to their requirements. Likewise, as revenues from consumables are recurring, vendors are strategizing to maximize their sales volume and profit margins by extending their existing ostomy bags product portfolio.

By Systems

The market is bifurcated into one-piece and two-piece systems. The two-piece systems segment dominates the global market and is expected to exhibit a CAGR of 3.93% over the forecast period. Investing in a two-part stoma system has several benefits. The skin barrier, often called a flange or wafer, can stay in place for two to four days with a two-piece ostomy pouch. Less frequent changes in the skin barrier are gentler on the skin. Frequent replacements with the one-piece system are often too much for sensitive skin.

Patients can easily change the pouch size with a two-piece system without removing the skin barrier. For intimate moments or during swimming, they can easily switch to a smaller bag and easily slip into a full-size bag for daily activities. A larger bag could be required during nights for a longer collection period. Ostomy bag changes with a two-part system are much faster and easier than with a one-part system.

By Usage

The market is divided into drainable and closed-end bags. The drainable segment accounts for a large market share and is expected to exhibit a CAGR of 3.66% over the forecast period. Drainable bags are available in both one-piece and two-piece options. A drainable bag allows users to empty the bag's contents and then reuse it. This type of bag is best suited for collecting fluid, such as bowel or urine movements, that are more consistent fluid. These bags can be used for a longer period. Hence, cost-conscious ostomates often use drainable bags compared to closed-end bags. Moreover, a drainable bag is typically best for people with an ileostomy or frequent discharge from their stoma throughout the day. Market players also offer specialized pouches with closable drainage valves for people with urostomies.

By Shape

The market is divided into flat and convex. The flat segment is the most significant contributor to the market and is predicted to exhibit a CAGR of 3.46% over the forecast period. Flat wafers are flexible to conform to the contours of the body. They generally work well for many stomates. The majority of ostomy bag rims have a flat shape, while a considerable number of ostomy patients express a preference or necessity for a curved rim. In addition, flat ostomy bags have a flat self-adhesive back, which means the bag can be held in a fixed position with little overhang. Flat devices offer more discretion. However, when people have a shallow or retractable stoma, the discharge can get under the wafers. This can lead to skin irritation and leakage.

By End User

The market is divided into hospitals, post-acute care centers, and home care. The hospital segment is the largest revenue contributor to the market and is expected to exhibit a CAGR of 3.51% over the forecast period. Ostomy surgery is generally performed by colorectal surgeons, gastrointestinal surgeons, general surgeons, urologists, and pediatric surgeons. Caring for the ostomate is extremely important to ensure the patient can lead a normal life after the surgery. Hospitals or physicians' offices offer the highest level of medical services for ostomy care, including colostomy, ileostomy, urostomy, fistulas, and leaky drainage tubes/points. Before discharge, the new ostomate and their caregiver are taught to empty the pouch, schedule changes, protect against discharge, and use accessories appropriately. Hospitals provide numerous services for patients with colorectal cancer, inflammatory bowel disease, bladder cancer, colon injuries, etc.

Recent Developments

• January 2023- Premier, Inc. awarded a sole-source SURPASS® contract for enterostomal therapy products to global medical device manufacturer Hollister Incorporated. Premier SURPASS members will have access, at their discretion, to the entire portfolio of Hollister Ostomy products under the terms of the new agreement.
• January 2023- OstomyCure, a clinical-stage medtech company that develops revolutionary technologies to improve the lives of people with a stoma, announced that it had reached a key patient recruitment milestone in the pivotal clinical trial of its proprietary TIES implant technology. TIES is an innovative titanium port implanted within a stoma and used to affix a lid that allows the user to open and close the stoma effectively.